Nanobiotix names board member, creates new department
This article was originally published in Scrip
Nanobiotix, a clinical-stage company developing cancer therapies, has named company chief financial officer Philippe Mauberna to its executive board. Mr Mauberna joined the company in May 2013. Furthermore, the Paris, France-based firm has named Sarah Gaubert head of its newly created communication and public affairs department. Prior to joining the firm, Ms Gaubert was an advisor to the French Presidency and several ministries including the Ministry of Health.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.